日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

No correlation of neutralizing antibody titers against the Omicron variant after a booster dose of COVID-19 vaccines with subsequent breakthrough Omicron infections among healthcare workers

医护人员接种新冠疫苗加强剂后,体内针对奥密克戎变异株的中和抗体滴度与随后发生的突破性奥密克戎感染之间无相关性。

Lee, Jeongjae; Park, Soonju; Kim, Ji Yeun; Lim, So Yun; Chang, Euijin; Bae, Seongman; Jung, Jiwon; Kim, Min Jae; Chong, Yong Pil; Lee, Sang-Oh; Choi, Sang-Ho; Kim, Yang Soo; Lee, Nakyung; Shum, David; Kim, Seungtaek; Jee, Youngmee; Kim, Sung-Han

Comparison of Waning Neutralizing Antibody Responses Against the Omicron Variant 6 Months After Natural Severe Acute Respiratory Syndrome Coronavirus 2 Infection (With or Without Subsequent Coronavirus Disease 2019 [COVID-19] Vaccination) Versus 2-Dose COVID-19 Vaccination

自然感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)(无论是否随后接种2019冠状病毒病[COVID-19]疫苗)6个月后,针对Omicron变异株的中和抗体反应减弱情况的比较,与接种两剂COVID-19疫苗后的比较

Lim, So Yun; Park, Soonju; Kim, Ji Yeun; Kim, Seungtaek; Jee, Youngmee; Kim, Sung-Han

Breakthrough infections and waning immune responses with ChAdOx1 nCoV-19 or mRNA vaccine in healthcare workers

医护人员接种 ChAdOx1 nCoV-19 或 mRNA 疫苗后出现突破性感染和免疫反应减弱的情况

Lim, So Yun; Jung, Jiwon; Kim, Ji Yeun; Park, Soonju; Kwon, Ji-Soo; Park, So Yeon; Kim, Sun-Kyung; Lim, Young-Ju; Kim, Eun Ok; Bae, Seongman; Kim, Min Jae; Chong, Yong Pil; Lee, Sang-Oh; Choi, Sang-Ho; Kim, Yang Soo; Lee, Nakyung; Kim, Kideok; Shum, David; Jee, Youngmee; Kim, Sung-Han

Immune Responses to the ChAdOx1 nCoV-19 and BNT162b2 Vaccines and to Natural Coronavirus Disease 2019 Infections Over a 3-Month Period

在三个月内,对 ChAdOx1 nCoV-19 和 BNT162b2 疫苗以及自然感染 2019 冠状病毒病 (COVID-19) 的免疫反应

Kim, Ji Yeun; Lim, So Yun; Park, Soonju; Kwon, Ji-Soo; Bae, Seongman; Park, Ji Young; Cha, Hye Hee; Seo, Mi Hyun; Lee, Hyun Jung; Lee, Nakyung; Kim, Kideok; Shum, David; Jee, Youngmee; Kim, Sung-Han

Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19

亟需建立标准化的转化药物开发平台:从新冠肺炎药物再利用中汲取的经验教训

Assmus, Frauke; Driouich, Jean-Sélim; Abdelnabi, Rana; Vangeel, Laura; Touret, Franck; Adehin, Ayorinde; Chotsiri, Palang; Cochin, Maxime; Foo, Caroline S; Jochmans, Dirk; Kim, Seungtaek; Luciani, Léa; Moureau, Grégory; Park, Soonju; Pétit, Paul-Rémi; Shum, David; Wattanakul, Thanaporn; Weynand, Birgit; Fraisse, Laurent; Ioset, Jean-Robert; Mowbray, Charles E; Owen, Andrew; Hoglund, Richard M; Tarning, Joel; Lamballerie, Xavier de; Nougairède, Antoine; Neyts, Johan; Sjö, Peter; Escudié, Fanny; Scandale, Ivan; Chatelain, Eric

Immunogenicity and Durability of Antibody Responses to Homologous and Heterologous Vaccinations with BNT162b2 and ChAdOx1 Vaccines for COVID-19

BNT162b2 和 ChAdOx1 疫苗对 COVID-19 同源和异源疫苗接种的免疫原性和抗体反应持久性

Kim, Dong-In; Lee, Seo Jin; Park, Soonju; Kim, Paul; Lee, Sun Min; Lee, Nakyung; Shum, David; Kim, Dong Ho; Kim, Eui Ho

A new high-content screening assay of the entire hepatitis B virus life cycle identifies novel antivirals.

针对乙型肝炎病毒整个生命周期的新型高内涵筛选检测方法,发现了新型抗病毒药物

Yang Jaewon, König Alexander, Park Soonju, Jo Eunji, Sung Pil Soo, Yoon Seung Kew, Zusinaite Eva, Kainov Denis, Shum David, Windisch Marc Peter

Comparison of Antibody and T Cell Responses Induced by Single Doses of ChAdOx1 nCoV-19 and BNT162b2 Vaccines

ChAdOx1 nCoV-19 和 BNT162b2 单剂量疫苗诱导的抗体和 T 细胞反应的比较

Kim, Ji Yeun; Bae, Seongman; Park, Soonju; Kwon, Ji-Soo; Lim, So Yun; Park, Ji Young; Cha, Hye Hee; Seo, Mi Hyun; Lee, Hyun Jung; Lee, Nakyung; Heo, Jinyeong; Shum, David; Jee, Youngmee; Kim, Sung-Han

Correlation between Reactogenicity and Immunogenicity after the ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccination

ChAdOx1 nCoV-19 和 BNT162b2 mRNA 疫苗接种后反应原性和免疫原性的相关性

Lim, So Yun; Kim, Ji Yeun; Park, Soonju; Kwon, Ji-Soo; Park, Ji Young; Cha, Hye Hee; Suh, Mi Hyun; Lee, Hyun Jung; Lim, Joon Seo; Bae, Seongman; Jung, Jiwon; Lee, Nakyung; Kim, Kideok; Shum, David; Jee, Youngmee; Kim, Sung-Han